Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Prostate Specific Antigen (PSA) Test Market from 2024 to 2025?

The market size for the prostate specific antigen (PSA) test has seen a swift expansion recently. The market, valued at $4.15 billion in 2024, is projected to escalate to $4.66 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.1%. The notable growth in the historic period can be credited to factors such as heightened awareness, a growing elderly population, advancements in medical and pharmaceutical sectors, and clinical recommendations.

What Is the Projected Market Size of the Prostate Specific Antigen (PSA) Test Market?

The market size of the prostate specific antigen (PSA) test is anticipated to witness significant expansion in the coming years. By 2029, the market is projected to reach $7.29 billion, with a compound annual growth rate (CAGR) of 11.9%. This predicted growth during the forecast period can be credited to factors such as the enhancement in test precision, the personalized medicine approach, and the global increase in the elderly population. Key trends during the same period are expected to include a shift towards combining biomarkers, technological advances, at-the-point-of-care testing, integrating digital health, along with an emphasis on early detection and prevention.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12576&type=smp

Who are the Major Competitors in the Prostate Specific Antigen (PSA) Test Market Outlook?

Major companies operating in the prostate specific antigen (PSA) test market include Siemens AG, F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Becton Dickinson and Company, PerkinElmer Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin SpA, OPKO Health Inc., R&D Systems Inc., Meso Scale Diagnostics LLC, Tosoh America Inc., Fujirebio Europe N.V., Boditech Med Inc., DRG International Inc., BioVision Inc., Enzo Life Sciences Inc., RayBiotech Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Elabscience, LifeSpan BioSciences Inc., American Laboratory Products Company Ltd., Accuquik Inc.

What Is Fueling Growth in the Prostate Specific Antigen (PSA) Test Market?

The acceleration in the rate of prostate cancer occurrences has been predicted to drive the advancement of the prostate-specific antigen (PSA) test market. Prostate cancer is found when there are cancer cells in the prostate gland, which is a part of both male and female reproductive systems. The PSA test, which measures the quantity of prostate-specific antigen in the bloodstream, is a commonly used method to screen for prostate cancer in men, aiding in early identification and risk evaluation. To illustrate, the American Society of Clinical Oncology (ASCO), a professional oncology group based in the US, reported in March 2023 that approximately 288,300 men in the US were found to have prostate cancer, and about 34,700 individuals passed away from it in 2023. Thus, the PSA test market is growing due to the increased detection of prostate cancer.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12576&type=smp

Which Prostate Specific Antigen (PSA) Test Market Segments Are Growing the Fastest?

The prostate specific antigen (PSA) test market covered in this report is segmented –

1) By Type: Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types

2) By Application: Screening, Post-Treatment Monitoring, Other Applications

3) By End User: Hospitals, Diagnostic Centers, Research Institutes, Other End Users

Subsegments:

1) By Clinical Laboratory Improvement Amendments (CLIA): CLIA Waived Tests, Non-CLIA Tests

2) By Enzyme-Linked Immunosorbent Assay (ELISA): Sandwich ELISA Kits, Competitive ELISA Kits

3) By Fluorescence Immunoassay (FIA): Point-Of-Care FIA, Laboratory-Based FIA

4) By Other Types: Chemiluminescent Immunoassay (CLIA), Radioimmunoassay (RIA)

Which Industry Trends Are Shaping the Future of the Prostate Specific Antigen (PSA) Test Market?

The rising trend in the prostate-specific antigen (PSA) test market is primarily driven by technological advancements. Major players in the market are leveraging this trend by developing state-of-the-art screening test tools to maintain their market dominance. In February 2023, for example, LynxDx Inc., an American diagnostic firm, introduced MyProstateScore 2.0, a non-invasive urine prostate cancer screening test. This pioneering test employs a mix of 18 biomarkers, inclusive of the innovative gene fusion T2:ERG, to create an individualised risk profile for each patient. The test also provides accurate stratified risk assessment information, which can guide medical decisions for patients with raised prostate-specific antigen (PSA) levels or inconsistent results from a digital rectal exam (DRE). This tool holds the potential to significantly enhance prostate cancer screening and treatment processes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/prostate-specific-antigen-psa-test-global-market-report

Which Countries Are Leading the Prostate Specific Antigen (PSA) Test Market?

North America was the largest region in the prostate specific antigen (PSA) test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate specific antigen (PSA) test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12576

This Report Delivers Insight On:

1. How big is the prostate specific antigen (psa) test market, and how is it changing globally?

2. Who are the major companies in the prostate specific antigen (psa) test market, and how are they performing?

3. What are the key opportunities and risks in the prostate specific antigen (psa) test market right now?

4. Which products or customer segments are growing the most in the prostate specific antigen (psa) test market?

5. What factors are helping or slowing down the growth of the prostate specific antigen (psa) test market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model